CLINICAL CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-02-20 1252d706m18(暂无昵称)

请问clinical cancer research可以有两位通讯作者吗？

192 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-02-20 1252d706m18(暂无昵称)

请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表:
decision send to author 是不是外审拒稿？还是编辑手里拒稿？

猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？

152 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-02-20 1252d706m18(暂无昵称)

请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表:
投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。
Decision Sent to Author 2017-12-12 09:45:27
Under Review 2017-11-06 11:09:57
Under Editorial Consideration 2017-11-06 10:02:41
Initial QC 2017-11-06 06:43:44
Manuscript Submission 2017-11-05 23:29:37

Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。
Decision Sent to Author 2017-12-12 09:45:27
Under Review 2017-11-06 11:09:57
Under Editorial Consideration 2017-11-06 10:02:41
Initial QC 2017-11-06 06:43:44
Manuscript Submission 2017-11-05 23:29:37

196 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-02-19 猪小屁

decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表:
投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。
Decision Sent to Author 2017-12-12 09:45:27
Under Review 2017-11-06 11:09:57
Under Editorial Consideration 2017-11-06 10:02:41
Initial QC 2017-11-06 06:43:44
Manuscript Submission 2017-11-05 23:29:37

Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。
Decision Sent to Author 2017-12-12 09:45:27
Under Review 2017-11-06 11:09:57
Under Editorial Consideration 2017-11-06 10:02:41
Initial QC 2017-11-06 06:43:44
Manuscript Submission 2017-11-05 23:29:37

192 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-02-19 猪小屁

你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表:
崩溃，原来Under review并不代表送审

Stage Start Date
Decision Sent to Author 2017-11-20 10:14:22
Under Review 2017-11-15 07:16:05
Under Editorial Consideration 2017-11-13 09:19:31
Initial QC 2017-11-13 05:34:41
Manuscript Submission 2017-11-12 21:56:06

misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审

Stage Start Date
Decision Sent to Author 2017-11-20 10:14:22
Under Review 2017-11-15 07:16:05
Under Editorial Consideration 2017-11-13 09:19:31
Initial QC 2017-11-13 05:34:41
Manuscript Submission 2017-11-12 21:56:06

139 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-02-19 猪小屁

问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表:
Under Review 2017-02-22 11:38:28
Under Editorial Consideration 2017-02-22 11:13:57
Initial QC 2017-02-21 02:28:34
Manuscript Submission 2017-02-17 02:59:54

ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28
Under Editorial Consideration 2017-02-22 11:13:57
Initial QC 2017-02-21 02:28:34
Manuscript Submission 2017-02-17 02:59:54

189 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-02-15 猪小屁

后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表:
怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing

lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing

185 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-01-13 Kaka5926

投稿命中率:25.0
经验分享：请问还有谁投过这个杂志，需要上传原始数据么？

160 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-01-10 hxun

不需要除非有明显存疑的biocell160 2019-01-01 发表::
revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表:
revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据

biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据

169 0

[GetPortalCommentsPageByObjectIdResponse(id=566996, encodeId=f758566996e2, content=请问clinical cancer research可以有两位通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 11:37:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566999, encodeId=a889566999bc, content=请问可以有两位通讯作者吗？猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, beContent=猪小屁 2019-02-19 00:00:00 发表: decision send to author 是不是外审拒稿？还是编辑手里拒稿？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566997, encodeId=f43056699e62, content=请问可以有两位通讯作者吗？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c1a2545270, createdName=1252d706m18(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566962, encodeId=bfa5566962c4, content=decision send to author 是不是外审拒稿？还是编辑手里拒稿？Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , beContent=Pis 2018-04-26 17:33:00 发表: 投过一篇，一审一般一个月左右，被拒，效率高，感觉这个杂志即使送审了，最后有将近一半还是要被拒，看人品。 Decision Sent to Author 2017-12-12 09:45:27 Under Review 2017-11-06 11:09:57 Under Editorial Consideration 2017-11-06 10:02:41 Initial QC 2017-11-06 06:43:44 Manuscript Submission 2017-11-05 23:29:37 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566963, encodeId=bd0256696310, content=你under review 是在编辑手里拒稿了？misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , beContent=misang 2017-11-21 08:48:00 发表: 崩溃，原来Under review并不代表送审 Stage Start Date Decision Sent to Author 2017-11-20 10:14:22 Under Review 2017-11-15 07:16:05 Under Editorial Consideration 2017-11-13 09:19:31 Initial QC 2017-11-13 05:34:41 Manuscript Submission 2017-11-12 21:56:06 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566964, encodeId=6d7c566964c5, content=问一下这个under review是宋外审了么？还是ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, beContent=ljj001ljj 2017-03-13 09:17:00 发表: Under Review 2017-02-22 11:38:28 Under Editorial Consideration 2017-02-22 11:13:57 Initial QC 2017-02-21 02:28:34 Manuscript Submission 2017-02-17 02:59:54, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Tue Feb 19 00:00:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566781, encodeId=1a33566e81d4, content=后来咋样啦，under review是不是还是编辑阶段？lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, beContent=lin920 2017-04-01 16:39:00 发表: 怎么都没人说话！各位大神，出来吼一嗓子啊，3.28投稿，29号Underreview，紧张ing, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/15/8e042c990aefecb540cf6f1f73f579d8.jpg, createdBy=80fd1653578, createdName=猪小屁, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565504, encodeId=529d565504ce, content=投稿命中率:25.0 经验分享：请问还有谁投过这个杂志，需要上传原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b741717985, createdName=Kaka5926, createdTime=Sun Jan 13 06:27:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565400, encodeId=4c945654000d, content=不需要除非有明显存疑的biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据biocell160 2019-01-01 16:30:00 发表: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=biocell160 2019-01-01 发表:: revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95942079757, createdName=hxun, createdTime=Thu Jan 10 00:00:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565037, encodeId=502256503edf, content=revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue Jan 01 16:30:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]

2019-01-01 biocell160

revisedsubmissionsrequireoriginalsourcefiles请问这杂志在修回的时候是不是要附上原始数据

193 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务